Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN – Get Rating) – HC Wainwright issued their Q2 2023 EPS estimates for Eledon Pharmaceuticals in a research report issued to clients and investors on Friday, May 26th. HC Wainwright analyst V. Bernardino anticipates that the company will earn ($0.47) per share for the quarter. The consensus estimate for Eledon Pharmaceuticals’ […]
Cantor Fitzgerald reissued their overweight rating on shares of Eledon Pharmaceuticals (NASDAQ:ELDN – Get Rating) in a report published on Monday morning, PriceTargets.com reports. Cantor Fitzgerald also issued estimates for Eledon Pharmaceuticals’ FY2023 earnings at ($1.83) EPS. Eledon Pharmaceuticals Stock Down 0.4 % Shares of NASDAQ:ELDN opened at $2.24 on Monday. The stock has a […]
Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN – Get Rating) – Stock analysts at SVB Leerink issued their Q1 2023 earnings estimates for Eledon Pharmaceuticals in a research note issued to investors on Tuesday, May 2nd. SVB Leerink analyst T. Smith expects that the company will earn ($0.71) per share for the quarter. The consensus estimate for Eledon […]
Read the latest stock market news on MarketBeat. Get real-time analyst ratings, dividend information, earnings results, financials, headlines, insider trades and options data for any stock.